Nachrichten Nachrichten Nachrichten

Nachrichten

Portfolio

ImmunOs Therapeutics Announces Initiation of Dosing in Phase 1 Trial of Lead Compound IOS-1002

24/05/2023 - 14:29

Corporate

Portfolio erreicht Rekordniveau trotz des schwierigen wirtschaftlichen Klimas

17/05/2023 - 06:58

Portfolio

Gimv Smart Industries invests in Witec, a fast-growing developer and manufacturer of high-precision and high-tech parts and systems for leading OEM customers

25/04/2023 - 17:43

Portfolio

Fronnt boosts its ambitious growth trajectory and energy transition mission with the entry of three new leading installation companies

25/04/2023 - 07:28

Portfolio

Gimv leads a 72 million € Series A financing round of Complement Therapeutics to finance further development of therapies for eye diseases

17/04/2023 - 07:27

Portfolio

FIRE1 Raises $25 Million to Revolutionize Heart Failure Home Monitoring

15/03/2023 - 16:27

Portfolio

Gimv participates in $105 million financing of Mediar Therapeutics alongside fellow leading global life sciences investors to develop first-in-class fibrosis therapies

15/03/2023 - 07:28

Corporate

Gimv recognized as an ESG top performer and joins the BEL® ESG Index

09/03/2023 - 07:30

Portfolio

Gimv participates in Paleo’s Series A of EUR 12m, a Belgian pioneer in the alternative protein market

21/02/2023 - 07:30

Portfolio

Olyn acquires Mozoo and strengthens its expertise in brand content

14/02/2023 - 14:16

Corporate

KÖBERL Group expandiert in dem attraktiven Segment der Rohrreinigung und Abwassertechnik

09/02/2023 - 07:30

Portfolio

AgTech leader Kind Technologies attracts growth capital from Avedon to further develop its innovative offering. Avedon additionally acquires Gimv’s majority stake in the group.

27/01/2023 - 07:00

Kontaktinformation

Pressekontact Pressekontact Pressekontact

Pressekontact

Haben Sie noch Fragen oder benötigen Sie weitere Informationen?
Bitte kontaktieren Sie uns.

Kontakt aufnehmen